China's Sinovac Set To Stage World's First Clinical Trials For Vaccine Defense To Enterovirus 71, Which Threatens Children Across Asia
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Leading Chinese vaccine developer Sinovac Biotech has filed an application with national drug regulators in Beijing to conduct clinical trials on the world's first defense to human enterovirus 71